Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Proteomics|February 14, 2006
Proteomic characterization of the effects of clofibrate on protein expression in rat liverJean-François Léonard, Martine Courcol, Claire Mariet, et al.
Plos One|November 13, 2015
Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex TissuesYaligara Veeranagouda, Pierrick Rival, Catherine Prades, et al.
Plos One|October 4, 2016
Correction: Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex TissuesYaligara Veeranagouda, Pierrick Rival, Catherine Prades, et al.
Environmental and Molecular Mutagenesis|August 30, 2005
Laboratory variability does not preclude identification of biological functions impacted by hydroxyureaArne Müller, Eric Boitier, Ting Hu, et al.
Toxicology and Applied Pharmacology|October 20, 2010
EU framework 6 project: predictive toxicology (PredTox)--overview and outcomeLaura Suter, Susanne Schroeder, Kirstin Meyer, et al.
Toxicology and Applied Pharmacology|February 15, 2011
A comparative integrated transcript analysis and functional characterization of differential mechanisms for induction of liver hypertrophy in the ratEric Boitier, Alexander Amberg, Valérie Barbié, et al.
BMC Biotechnology|February 3, 2018
Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCRRussell D Wolfinger, Sudheer Beedanagari, Eric Boitier, et al.
Translational Oncology|December 3, 2025
Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancerAnas Gazzah, Nils Ternès, Joon Sang Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast CancerSara M Tolaney, Arlene Chan, Katarina Petrakova, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 5, 2011
Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the ratMark R Fielden, Alex Adai, Robert T Dunn, et al.
Pageof 3